Recently published research from the United States and Australian reveals two ways to slow or prevent cognitive decline.
Inverse link found for antioxidant levels, all-cause dementia
May 04, 2022
Serum lutein+zeaxanthin and β-cryptoxanthin levels were inversely associated with incident all-cause dementia.
15 percent of off-label antipsychotic use in assisted living may be inappropriate, but nursing home reduction...
By
Kimberly Bonvissuto
Sep 14, 2021
The rate of potentially inappropriate prescribing of drugs in assisted living is 15% for antipsychotics and 21% for antianxiety medications, according to the authors of a new study published in JAMDA,...
One way to give people with dementia a chance to lead fuller lives
By
Jennifer Brush
Sep 11, 2017
With the number of people in whom dementia is diagnosed growing at alarming rates, the need for effective memory care programs is more important than ever. One international program combines dementia care...
Retinal layer thickness linked to cognitive decline in older adults
May 27, 2022
Thinner baseline total macular retinal nerve fiber layer thickness was associated with a larger decline in cognitive function test scores during follow-up.
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Assisted living memory care admission reduces odds of SNF placement, acute care stays, study finds
By
Alicia Lasek
Jan 07, 2022
Older adults living with dementia who move into memory care units in assisted living communities are less likely to experience a skilled nursing facility or a hospital stay than their peers who move into...
Physicians less likely to test for pulmonary embolism in dementia patients
Oct 01, 2021
The findings were seen in patients with dementia presenting with clinical factors known to be predictive of pulmonary embolism risk.
Higher triglyceride levels linked to lower dementia risk
Oct 26, 2023
Similar findings were seen in a a subcohort of participants with APOE-ε4 genetic data and in an external validation cohort.
Cognitive impairment delayed with genetic variant
Jun 20, 2024
The onset of cognitive impairment was delayed among those heterozygous for the apolipoprotein E3 Christchurch variant.